Fig. 3From: Synthesis of thiazoloquinolinone derivatives: molecular docking, MD simulation, and pharmacological evaluation as VEGFR-2 inhibitorsSuperimposition of the co-crystal ligand (blue) and the docked ligand (yellow)Back to article page
